Fundz

Fennec Announces Incremental $5 Million Investment From Petrichor

PUBLIC · FENCDec 05, 2023

Amount Raised

$5 Million

Round Type

Venture

Research Triangle ParkManufacturingBiotechnologyPharmaceutical

Description

Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company focused on improving the lives of children with cancer, today announced the third closing of $5 million senior secured promissory notes under the existing agreement with Petrichor. The original investment agreement provided access to up to $20 million of additional financing through December 31, 2023. As part of this closing, Fennec and Petrichor have amended the agreement to provide access to up to $15 million of additional financing through December 31, 2024.

Quick answer

Fennec Pharmaceuticals raised $5 Million in a funding round, dated December 5, 2023. Fennec Pharmaceuticals is based in Research Triangle Park, North Carolina, United States.

How much did Fennec Pharmaceuticals raise?
Fennec Pharmaceuticals raised $5 Million in a funding round on December 5, 2023.
What does Fennec Pharmaceuticals do?
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States.
Where is Fennec Pharmaceuticals based and how big is it?
Fennec Pharmaceuticals is based in Research Triangle Park, North Carolina, United States. Fundz records about 36 employees.
Who are the decision-makers at Fennec Pharmaceuticals?
Fundz holds 1 contact at Fennec Pharmaceuticals. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and Manufacturing around the same time

Companies in the same sectors as Fennec Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Liquidia raised $100M (Funding Round) on January 4, 2024.
  • Allarity Therapeutics raised $400K (Seed) on January 18, 2024.
  • Ratio Therapeutics raised $50M (Series B) on January 17, 2024.
  • Lynch Regenerative Medicine raised $3.8M (Seed) on January 17, 2024.
  • PolyPid raised $35M on January 9, 2024.
  • ViaLase raised $45M (Seed) on January 5, 2024.

Who to call at Fennec Pharmaceuticals, and when

A new round usually means Fennec Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Fennec Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Fennec Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Fennec Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Fennec Pharmaceuticals

Location

Research Triangle Park, North Carolina, United States

About

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Fennec Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts6 people are listed at Fennec Pharmaceuticals. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Fennec Pharmaceuticals's next move

See what Strategic adds

Fennec Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.